🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Broad Objectives: To determine the comparative efficacy of commonly employe...
Status
Completed
Location
Vanderbilt University Medical Center
Start Date
2016-02
Trial ID
NCT02606253
Treatments Being Tested
The objective of this study was to investigate the bioequivalence of Mylan ...
Status
Completed
Location
Kendle International Inc.
Start Date
2003-10
Trial ID
NCT00649181
Treatments Being Tested
The purpose of this study is to examine whether administering metolazone 60...
Status
Terminated
Location
University of Maryland Medical Center
Start Date
2019-01-01
Trial ID
NCT03746002
Treatments Being Tested
Aim to identify the best strategy for treating acute heart failure (AHF) wi...
Status
Recruiting
Location
Amager-Hvidovre Hospital
Start Date
2024-09-05
Trial ID
NCT06166654
Treatments Being Tested
The objective of this study was to investigate the bioequivalence of Mylan ...
Status
Completed
Location
Kendle International Inc.
Start Date
2004-02
Trial ID
NCT00650195
Treatments Being Tested
To assess the effect of dapagliflozin compared with metolazone, added to fu...
Status
Unknown
Location
Glasgow Royal Infirmary
Start Date
2021-04-27
Trial ID
NCT04860011
Treatments Being Tested
The primary objective of the study is to compare efficacy of metolazone and...
Status
Terminated
Location
University of Virginia Health System
Start Date
2018-06-01
Trial ID
NCT03574857
Treatments Being Tested
The objective of this study was to investigate the bioequivalence of Mylan ...
Status
Completed
Location
Gateway Medical Research, Inc.
Start Date
2002-12
Trial ID
NCT00649051
Treatments Being Tested
The RADAR-Canada trial is a pilot RCT undertaken to assess the acceptabilit...
Status
Unknown
Location
Unity Health Toronto
Start Date
2024-05-01
Trial ID
NCT06326112
Treatments Being Tested